Deal Watch: Fresenius Drops Bid For Akorn, Citing Data-Integrity Concerns

 
• By Dave Wallace, Joseph Haas, Michael Cipriano, John Davis, Lucie Ellis-Taitt, and Eleanor Malone

Janssen and Bristol team to develop next-generation oral anticoagulant, while UCB buys Proximagen's nasal spray candidate and Duke spinout focused on genomics.

DealWatch_1200x675

More from Strategy

More from Business